Department of Otolaryngol Head & Neck Surg, the First Affiliated Hospital of Hebei North University, Zhangjiakou City, Hebei, Peoples R China,
Department of Otolaryngol Head & Neck Surg, the First Affiliated Hospital of Hebei North University, Zhangjiakou City, Hebei, Peoples R China.
Arch Endocrinol Metab. 2024 Feb 23;68:e210541. doi: 10.20945/2359-4292-2021-0541.
As the most prevalent type of thyroid malignancy, papillary thyroid carcinoma (PTC) accounts for over 80% of all thyroid cancers. Circular RNAs (circRNAs) have been found to regulate multiple cancers, including PTC.
Quantitative real-time polymerase chain reaction (qRT-PCR) and western blotting were used to analyse RNA and protein levels. Fluorescence in situ hybridization (FISH) was used to detect the distribution of the target genes. Functional experiments and animal experiments were implemented to analyse the biological functions of target genes in vitro and in vivo. Luciferase reporter, RNA pulldown, RNA binding protein immunoprecipitation (RIP) and mRNA stability assays were used to probe the underlying mechanisms.
CircSEMA6Awas found to be upregulated in PTC tissues and cells, and its circular structure was verified. CircSEMA6A promotes PTC cell migration and invasion. Moreover, circSEMA6A functions as a competing endogenous RNA (ceRNA) to upregulate proline rich and Gla domain 4 (PRRG4) expression by sponging microRNA-520h (miR-520h). CircSEMA6A recruits ELAV1 to stabilize PRRG4 mRNA and drives PTC progression via PRRG4.
CircSEMA6A upregulates PRRG4 by targeting miR-520h and recruiting ELAVL1 to affect the invasion and migration of PTC cells, offering insight into the molecular mechanisms of PTC.
作为最常见的甲状腺恶性肿瘤,甲状腺乳头状癌 (PTC) 占所有甲状腺癌的 80%以上。环状 RNA (circRNA) 已被发现可调节多种癌症,包括 PTC。
采用实时定量聚合酶链反应 (qRT-PCR) 和蛋白质印迹法分析 RNA 和蛋白质水平。采用荧光原位杂交 (FISH) 检测靶基因的分布。实施功能实验和动物实验,在体外和体内分析靶基因的生物学功能。采用荧光素酶报告基因、RNA 下拉、RNA 结合蛋白免疫沉淀 (RIP) 和 mRNA 稳定性测定来探讨潜在机制。
CircSEMA6A 在 PTC 组织和细胞中上调,并验证了其环状结构。CircSEMA6A 促进 PTC 细胞迁移和侵袭。此外,CircSEMA6A 作为竞争性内源性 RNA (ceRNA) 通过海绵 microRNA-520h (miR-520h) 上调富含脯氨酸和 Gla 结构域 4 (PRRG4) 的表达。CircSEMA6A 招募 ELAV1 稳定 PRRG4 mRNA,并通过 PRRG4 驱动 PTC 进展。
CircSEMA6A 通过靶向 miR-520h 上调 PRRG4,并通过募集 ELAVL1 影响 PTC 细胞的侵袭和迁移,为 PTC 的分子机制提供了新的见解。